BARCLAYS PLC - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 60 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$31,000
-36.7%
7,268
-21.1%
0.00%
Q2 2021$49,000
+1533.3%
9,211
+1146.4%
0.00%
Q1 2021$3,000739
+14680.0%
0.00%
Q4 2020$0
-100.0%
5
-99.9%
0.00%
Q3 2020$15,000
-59.5%
4,505
-59.3%
0.00%
Q2 2020$37,000
-19.6%
11,057
-9.7%
0.00%
Q1 2020$46,000
-67.1%
12,243
-47.3%
0.00%
Q4 2019$140,000
+6.1%
23,231
+31.7%
0.00%
Q3 2019$132,000
-84.9%
17,646
-72.7%
0.00%
-100.0%
Q2 2019$875,000
+1246.2%
64,600
+434.0%
0.00%
Q1 2019$65,000
-36.3%
12,098
-64.9%
0.00%
Q4 2018$102,000
-26.1%
34,430
+104.1%
0.00%
Q3 2018$138,000
-8.0%
16,872
+9.6%
0.00%
Q2 2018$150,000
+2.0%
15,400
-9.4%
0.00%
Q1 2018$147,000
+14.0%
16,994
+64.2%
0.00%
Q4 2017$129,000
+143.4%
10,350
+63.6%
0.00%
Q3 2017$53,000
+430.0%
6,327
+910.7%
0.00%
Q2 2017$10,000
-95.2%
626
-94.0%
0.00%
Q1 2017$209,000
+6866.7%
10,400
+2703.2%
0.00%
Q2 2016$3,0003710.00%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Beryl Capital Management LLC 4,898,927$6,246,1320.70%
Yakira Capital Management, Inc. 620,019$790,5240.22%
Crystalline Management Inc. 230,817$294,2920.21%
DELTEC ASSET MANAGEMENT LLC 475,000$605,6250.14%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 2,283,979$2,912,0730.12%
PenderFund Capital Management Ltd. 123,444$2130.06%
FIFTH LANE CAPITAL, LP 100,000$127,0000.04%
CSS LLC/IL 476,831$607,9600.04%
Penserra Capital Management LLC 220,858$2800.01%
King Wealth Management Group 16,000$200.00%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders